Sfoglia per AUTORE
BOSSI P
Collezione ASL Cuneo 1

  

Items : 2

Pembrolizumab and olaparib in recurrent/metastatic, platinum resistant nasopharyngeal cancer: The POINT study in Annals of Oncology

2024
ASL Cuneo 1

Gurizzan C; Farinatti S; Alberti A; Bonomo P; Resteghini C; Alfieri S; Bergamini C; Perri F; Moretti G; Galizia D; Cossu Rocca M; Sponghini AP; Secondino S; Zamparini M; Lorini L; Bossi P;

Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial. in Frontiers in oncology / Front Oncol. 2022 Sep 15;12:925366. doi: 10.3389/fonc.2022.925366. eCollection 2022.

2022
AO Ordine Mauriziano
AO Cuneo
ASL Cuneo 1
AOU Alessandria

Mariani G; Di Pede P; Spinelli GP; Santini D; Zustovich F; Bossi P; Di Maio M; Numico G; Gunnellini M; Rossi M; Giordano M; Corsi DC; Fabi A; Berruti A; Coletta D; Sbrana A; Galli L; Miccinesi G; Velutti L; Sammarco E; Roila F; Antonuzzo A; Ripamonti CI;